|
|
Prepublished online as a Blood First Edition Paper on July 25, 2002; DOI 10.1182/blood-2002-01-0303.
Previous Article | Table of Contents | Next Article 
Blood, 15 November 2002, Vol. 100, No. 10, pp. 3597-3603
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Differential movements of VE-cadherin and PECAM-1 during
transmigration of polymorphonuclear leukocytes through human
umbilical vein endothelium
Wen-Hong Su,
Hsiun-ing Chen, and
Chauying J. Jen
From the Department of Physiology and Institute of
Basic Medical Sciences, College of Medicine, National Cheng-Kung
University, Tainan, Taiwan, Republic of China.
Most existing evidence regarding junction protein movements during
transendothelial migration of leukocytes comes from taking postfixation
snap shots of the transendothelial migration process that happens on a
cultured endothelial monolayer. In this study, we used junction
protein-specific antibodies that did not interfere with the
transendothelial migration to examine the real-time movements of
vascular endothelial-cadherin (VE-cadherin) and platelet/endothelial cell adhesion molecule-1 (PECAM-1) during transmigration of
polymorphonuclear leukocytes (PMNs) either through a cultured
endothelial monolayer or through the endothelium of dissected human
umbilical vein tissue. In either experimental model system, both
junction proteins showed relative movements, not transient
disappearance, at the PMN transmigration sites. VE-cadherin moved away
to different ends of the transmigration site, whereas PECAM-1 opened to
surround the periphery of a transmigrating PMN. Junction proteins
usually moved back to their original positions when the PMN
transmigration process was completed in less than 2 minutes. The
relative positions of some junction proteins might rearrange to form a
new interendothelial contour after PMNs had transmigrated through
multicellular corners. Although transmigrated PMNs maintained good
mobility, they only moved laterally underneath the vascular endothelium
instead of deeply into the vascular tissue. In conclusion, our results
obtained from using either cultured cells or vascular tissues showed
that VE-cadherin-containing adherent junctions were relocated aside,
not opened or disrupted, whereas PECAM-1-containing junctions were
opened during PMN transendothelial migration.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. F. Nottebaum, G. Cagna, M. Winderlich, A. C. Gamp, R. Linnepe, C. Polaschegg, K. Filippova, R. Lyck, B. Engelhardt, O. Kamenyeva, et al.
VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF
J. Exp. Med.,
November 24, 2008;
205(12):
2929 - 2945.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vestweber
VE-Cadherin: The Major Endothelial Adhesion Molecule Controlling Cellular Junctions and Blood Vessel Formation
Arterioscler Thromb Vasc Biol,
February 1, 2008;
28(2):
223 - 232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-H. Su, H.-i. Chen, and C. J. Jen
Polymorphonuclear leukocyte transverse migration induces rapid alterations in endothelial focal contacts
J. Leukoc. Biol.,
September 1, 2007;
82(3):
542 - 550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sircar, P. F. Bradfield, M. Aurrand-Lions, R. J. Fish, P. Alcaide, L. Yang, G. Newton, D. Lamont, S. Sehrawat, T. Mayadas, et al.
Neutrophil Transmigration under Shear Flow Conditions In Vitro Is Junctional Adhesion Molecule-C Independent
J. Immunol.,
May 1, 2007;
178(9):
5879 - 5887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kogata, Y. Arai, J. T. Pearson, K. Hashimoto, K. Hidaka, T. Koyama, S. Somekawa, Y. Nakaoka, M. Ogawa, R. H. Adams, et al.
Cardiac Ischemia Activates Vascular Endothelial Cadherin Promoter in Both Preexisting Vascular Cells and Bone Marrow Cells Involved in Neovascularization
Circ. Res.,
April 14, 2006;
98(7):
897 - 904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cernuda-Morollon and A. J. Ridley
Rho GTPases and Leukocyte Adhesion Receptor Expression and Function in Endothelial Cells
Circ. Res.,
March 31, 2006;
98(6):
757 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Soghomonians, T. L. Thirkill, N. F. Mariano, A. I. Barakat, and G. C. Douglas
Effect of Aqueous Tobacco Smoke Extract and Shear Stress on PECAM-1 Expression and Cell Motility in Human Uterine Endothelial Cells
Toxicol. Sci.,
October 1, 2004;
81(2):
408 - 418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Rao, T. V. Betz, D. J. Lamont, M. B. Kim, S. K. Shaw, R. M. Froio, F. Baleux, F. Arenzana-Seisdedos, R. Alon, and F. W. Luscinskas
Elastase Release by Transmigrating Neutrophils Deactivates Endothelial-bound SDF-1{alpha} and Attenuates Subsequent T Lymphocyte Transendothelial Migration
J. Exp. Med.,
September 20, 2004;
200(6):
713 - 724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liu, S. K. Shaw, S. Ma, L. Yang, F. W. Luscinskas, and C. A. Parkos
Regulation of Leukocyte Transmigration: Cell Surface Interactions and Signaling Events
J. Immunol.,
January 1, 2004;
172(1):
7 - 13.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. N. Stein, J. R. Gamble, S. M. Pitson, M. A. Vadas, and Y. Khew-Goodall
Activation of Endothelial Extracellular Signal-Regulated Kinase Is Essential for Neutrophil Transmigration: Potential Involvement of a Soluble Neutrophil Factor in Endothelial Activation
J. Immunol.,
December 1, 2003;
171(11):
6097 - 6104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Hermant, S. Bibert, E. Concord, B. Dublet, M. Weidenhaupt, T. Vernet, and D. Gulino-Debrac
Identification of Proteases Involved in the Proteolysis of Vascular Endothelium Cadherin during Neutrophil Transmigration
J. Biol. Chem.,
April 11, 2003;
278(16):
14002 - 14012.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|